|
All
|
Monofocal
|
Multifocal
|
p-value*
|
---|
N
|
176
|
93
|
83
| |
CDMS %* over 2 years
|
45%
|
47%
|
44%
|
0.7052†
|
Median annualized cumulative number of NALs over the study (quartiles)
|
3.2
(0.96–10.4)
|
3.0
(0.5–9.4)
|
3.6
(1.0–12.5)
|
0.4698‡
|
- *Compares monofocal vs. multifocal patients
- NAL: newly active lesion
- CDMS: clinically definite MS
-
† Kaplan-Meier estimate at day 720, Log rank test
-
‡Wilcoxon test